Stille AB (STIL) AI Stock Analysis

• Market Cap: kr2.04B
• Dividend Yield: N/A
• Average Volume (3M): 6.57K
• Price to Earnings (P/E): 14.5
• Beta (1Y): 0.21
• Revenue Growth: 13.36%
• EPS Growth: -20.56%
• Country: SE
• Employees: 162
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): 3.37
• Shares Outstanding: 8,985,447
• 10 Day Avg. Volume: 9,615
• 30 Day Avg. Volume: 6,571
• PEG Ratio: -7.86
• Price to Book (P/B): 2.48
• Price to Sales (P/S): 3.10
• P/FCF Ratio: 112.94
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 8.7
• Revenue Forecast (FY): kr651.75M

• Rating: 73 Outperform
• Price Target: kr236.00 ▲(26.54% Upside)
• Action: Upgraded Date: 03/27/26
• Date: Action: Upgraded 03/27/26

The score is driven primarily by solid financial quality—especially a very conservative balance sheet and healthy margins—partly offset by weaker cash-flow conversion and slower recent growth. Technicals are supportive with the stock trading above key moving averages, though momentum is approaching overbought levels. Valuation is reasonable on P/E, but dividend yield information is unavailable.

Positive Factors

Conservative balance sheet

Zero reported debt and materially reduced leverage give the company durable financial flexibility. That conservatism supports capital spending for product development, cushions procurement-cycle volatility in hospitals, and preserves optionality for opportunistic M&A or shareholder returns without stressing liquidity.

Negative Factors

Slowing revenue momentum

A pronounced deceleration in top-line growth reduces leverage from scale and may reflect market saturation, tougher procurement in healthcare, or competitive pressure. Slower revenue expansion constrains future margin expansion and limits the pace at which the company can reinvest to drive long-term earnings growth.

Stille AB Business Overview & Revenue Model

Company Description

Stille AB develops, manufactures, and sells surgical instruments in Sweden and internationally. It offers artery forceps and ligature clamps; bone cutters and rongeurs; clamps, curettes, raspatories, elevators, forceps, and micro instruments; need...

Read more

Stille AB develops, manufactures, and sells surgical instruments in Sweden and internationally. It offers artery forceps and ligature clamps; bone cutters and rongeurs; clamps, curettes, raspatories, elevators, forceps, and micro instruments; need...

How the Company Makes Money

Stille makes money mainly by selling medical-technology products and related services to healthcare providers. Its core revenue streams are (1) sales of surgical instruments used in surgical procedures, and (2) sales of surgical tables used in ope...

Read more

Stille makes money mainly by selling medical-technology products and related services to healthcare providers. Its core revenue streams are (1) sales of surgical instruments used in surgical procedures, and (2) sales of surgical tables used in ope...

Stille AB Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	567.63M	569.95M	294.89M	246.35M	187.09M
Gross Profit	287.97M	295.64M	132.17M	111.57M	83.46M
EBITDA	72.69M	118.97M	56.04M	44.78M	28.89M
Net Income	55.70M	58.21M	26.65M	27.32M	16.10M
Balance Sheet
Total Assets	1.05B	1.00B	804.89M	342.55M	308.85M
Cash, Cash Equivalents and Short-Term Investments	118.66M	158.49M	241.45M	36.68M	27.80M
Total Debt	123.26M	63.09M	62.94M	70.77M	81.48M
Total Liabilities	345.54M	301.70M	172.64M	152.74M	160.75M
Stockholders Equity	708.71M	699.40M	632.25M	189.81M	148.10M
Cash Flow
Free Cash Flow	15.59M	59.24M	24.37M	23.89M	-11.74M
Operating Cash Flow	36.05M	73.53M	37.28M	31.94M	7.28M
Investing Cash Flow	-104.30M	-330.31M	-12.90M	-8.04M	-51.90M
Financing Cash Flow	36.16M	171.40M	178.99M	-18.54M	33.22M

Stille AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 186.50
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:STIL, the sentiment is Positive. The current price of 186.5 is below the 20-day moving average (MA) of 207.00, below the 50-day MA of 189.03, and below the 200-day MA of 199.64, indicating a bullish trend. The MACD of 11.28 indicates Negative momentum. The RSI at 67.17 is Neutral, neither overbought nor oversold. The STOCH value of 75.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:STIL.

Stille AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
STIL	73 Outperform	kr2.04B	14.54	―	―	13.36%	-20.56%
PAX	56 Neutral	kr1.07B	-74.03	-4.20%	―	21.71%	-80.37%
CRAD.B	55 Neutral	kr915.08M	168.74	6.93%	―	-5.80%	-65.99%
SEZI	52 Neutral	kr719.26M	-5.78	-36.55%	―	62.24%	21.16%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
OSSD	47 Neutral	kr637.21M	-24.57	―	―	38.43%	57.76%
SEDANA	44 Neutral	kr921.85M	-17.24	-4.42%	―	13.48%	28.98%